A true Manchester partnership advancing precision medicine

Yourgene spoke with Joely Irlam-Jones, a Research Associate at the University of Manchester and Director and CEO of ManTRa Diagnostics, a spin-out company from the University of Manchester that is developing patient stratification solutions to personalise medicine and improve cancer treatment outcomes. The team have developed tumour-site-specific gene expression signatures which indicate the oxygen status of the tumour. ManTRa and the Yourgene Genomic Services team have a longstanding history of over 10 years working together on this development.